Log in to search using one of your social media accounts:

 

Mevion files for FDA clearance for S250i proton therapy system
Mevion Medical Systems said yesterday it submitted a 510(k) premarket notification to the FDA for its Mevion S250i proton therapy system with Hyperscan pencil beam scanning tech. The Mevion S250i features improved pencil beam scanning fields and Hyperscan pencil beam scanning tech to allow for faster energy layer switching, the Littleton, Mass.-based company said. “We focused on addressing the challenges clinicians faced with 1st generation systems and engineered a novel and transformative solution,” CEO Joseph Jachinowski said in a press release. The system also features the company’s Adaptive Apert...
Source: Mass Device - September 19, 2017 Category: Medical Devices Authors: Fink Densford Tags: Food & Drug Administration (FDA) Oncology Regulatory/Compliance Mevion Medical Systems Source Type: news

Mevion submits 510(k) to FDA for proton therapy system
Mevion Medical Systems has submitted a 510(k) premarket notification to the...Read more on AuntMinnie.comRelated Reading: Mevion touts scanning milestone Mevion joins forces with MedPhoton Mevion completes milestone installation Mevion completes Fla. installation Mevion, RaySearch partner on info system (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 18, 2017 Category: Radiology Source Type: news

MedLever and HKSH collaborate for new MR-guided proton therapy solution
MedLever and the Hong Kong Sanatorium& Hospital (HKSH) have collaborated to develop the information backbone to support the new MR-guided proton therapy solution, which is being developed at the hospital. (Source: Hospital Management)
Source: Hospital Management - September 12, 2017 Category: Hospital Management Source Type: news

Brain imaging can't prove chronic pain
A task force of the International Association for the Study of Pain has concluded...Read more on AuntMinnie.comRelated Reading: fMRI, EEG may detect consciousness in TBI patients EEG device could reduce head CT scans Calif. center to explore proton therapy for pain relief Diagnosing chronic back pain: More than just looking at images MR spots reason for chronic groin pain, but may not alter management (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 11, 2017 Category: Radiology Source Type: news

IBA posts half-year revenue increases
Proton therapy firm Ion Beam Applications (IBA) posted revenue increases for...Read more on AuntMinnie.comRelated Reading: Philips, Varian, IBA partner on Singapore cancer center IBA inks Va. installation deal IBA to show updated synthesizer at SNMMI 2017 IBA posts healthy Q1 revenue rise IBA Molecular forms Curium as new radiopharmacy player (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 24, 2017 Category: Radiology Source Type: news

Belgium ’ s Ion Beam Applications dives on slowing growth
(Reuters) — Belgian proton therapy specialist Ion Beam Applications (EBR:IBAB) lost a third of its $1 billion market value today after it cut its guidance for 2018 and 2019, blaming project delays and increased competition. The company is a leading maker of machines that deliver cancer-fighting proton beams, a super-precise form of radiation, but it has been beset by delays in the construction of buildings to house its proton therapy systems by third-party contractors. IBAB shares closed down -35.1% at €20.00 ($23.64) apiece today in Brussels. “The first half of 2017 has been slower, in line with the ...
Source: Mass Device - August 24, 2017 Category: Medical Devices Authors: Brad Perriello Tags: MassDevice Earnings Roundup Radiosurgery Wall Street Beat ionbeamapplications Source Type: news

$1B Hamlin community 1 step closer to getting proton therapy center
The new facility will create about 100 new clinical and administrative jobs. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - August 21, 2017 Category: Health Management Authors: Veronica Brezina Source Type: news

$1B Hamlin community 1 step closer to getting proton therapy center
The new facility will create about 100 new clinical and administrative jobs. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - August 21, 2017 Category: Biotechnology Authors: Veronica Brezina Source Type: news

Proton Therapy Insurance Coverage: Fair or Foul? Proton Therapy Insurance Coverage: Fair or Foul?
At one center, the vast majority of requests for coverage for treatment of a set of cancers were approved, although some approvals required going through an appeal process. But was this well done?Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 9, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Insurers reverse 97% of pediatric proton denials on appeal
Insurance companies wind up covering proton therapy treatment for pediatric...Read more on AuntMinnie.comRelated Reading: How to avoid radiology claim denials: Medical necessity Pediatric proton therapy treatments on the rise (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 8, 2017 Category: Radiology Source Type: news

97 percent of insurance denials in pediatric proton patients overturned on appeal
(University of Pennsylvania School of Medicine) Insurance companies end up covering proton therapy treatment for pediatric cancer patients in 97 percent of the cases they originally deny once those decisions are appealed. Researchers from the Perelman School of Medicine at the University of Pennsylvania analyzed five years of coverage decisions at Penn's Roberts Proton Therapy Center. They discovered that roughly one in 10 pediatric cancer patients are initially denied coverage for the cutting edge and costly treatment - yet nearly all patients ultimately get approval. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 7, 2017 Category: Cancer & Oncology Source Type: news

Concurrent Chemo, Proton Therapy Promising in Advanced Lung Cancer
Five-year results of a single-institution study show that proton beam radiotherapy given concurrently with chemotherapy offers promising clinical outcomes with good toxicity results compared with historical data. (Source: CancerNetwork)
Source: CancerNetwork - August 3, 2017 Category: Cancer & Oncology Authors: Dave Levitan Tags: Lung Cancer News Source Type: news

Concurrent chemotherapy, proton therapy improves survival in patients with advanced lung cancer
(University of Texas M. D. Anderson Cancer Center) For patients with advanced, inoperable stage 3 lung cancer, concurrent chemotherapy and the specialized radiation treatment, proton therapy, offers improved survival compared to historical data for standard of care, according to a new study from The University of Texas MD Anderson Cancer Center. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 20, 2017 Category: International Medicine & Public Health Source Type: news

90-ton cyclotron installed at new Emory Proton Therapy Center (SLIDESHOW)
A 90-ton cyclotron was installed Thursday at the new Emory Proton Therapy Center in Midtown in an event attended by Mayor Kasim Reed and Dr. Jonathan Lewin, CEO of Emory Healthcare. Check out the adjacent slideshow for photos from the event. The 90-ton piece of machinery uses powerful magnetic and electrical fields to accelerate protons to focus precisely on cancer cells. The cyclotron was driven up from the Port of Savannah by police escort. Atlanta Business Chronicle reported June 30 that the… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - July 13, 2017 Category: Health Management Authors: Ellie Hensley Source Type: news

90-ton cyclotron installed at new Emory Proton Therapy Center (SLIDESHOW)
A 90-ton cyclotron was installed Thursday at the new Emory Proton Therapy Center in Midtown in an event attended by Mayor Kasim Reed and Dr. Jonathan Lewin, CEO of Emory Healthcare. Check out the adjacent slideshow for photos from the event. The 90-ton piece of machinery uses powerful magnetic and electrical fields to accelerate protons to focus precisely on cancer cells. The cyclotron was driven up from the Port of Savannah by police escort. Atlanta Business Chronicle reported June 30 that the… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - July 13, 2017 Category: Biotechnology Authors: Ellie Hensley Source Type: news

American Society for Radiation Oncology Updates Insurance Coverage Recommendations for Proton Therapy
Proton beam therapy model policy recommends expanded access to advanced radiation therapy treatment for cancer patients ARLINGTON, Va., July 13, 2017 -- (Healthcare Sales & Marketing Network) -- The American Society for Radiation Oncology (ASTRO) has i... Devices, Oncology ASTRO , proton beam, proton therapy, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 13, 2017 Category: Pharmaceuticals Source Type: news

ASTRO updates insurance coverage recommendations for proton therapy
(American Society for Radiation Oncology) The American Society for Radiation Oncology (ASTRO) has issued an update to its recommendations for medical insurance coverage regarding the use of proton beam therapy to treat cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 13, 2017 Category: Cancer & Oncology Source Type: news

Inova Health System inks $60 million proton therapy deal
Inova Health System plans to begin offering proton beam therapy at its Inova Schar Cancer Institute by 2020 after signing a $60 million contract for a proton system from Reston-based Ion Beam Applications S.A. The deal comes after Inova received regulatory permission to build a $92.3 million center that offers proton beam therapy and MRI simulator services. The project is part of broader ambitions for Inova's personalized health campus to "develop a national comprehensive cancer program for both… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - July 7, 2017 Category: Biotechnology Authors: Tina Reed Source Type: news

Varian Medical wins FDA nod for Halcyon radiotherapy cancer treatment system
Varian Medical (NYSE:VAR) said today it won FDA 510(k) clearance for its Halcyon image-guided volumetric intensity modulated radiotherapy cancer treatment system. The Palo Alto, Calif.-based company said its Halcyon IMRT system features improvements that make it more comfortable for patients and streamline operator’s workflow, only requiring 9 steps from start to treatment, down from 30 steps in legacy machines. “We are proud that Halcyon has now received both 510(k) clearance and CE mark. With its human-centered and user-friendly design, Halcyon is engineered to revolutionize clinical workflow. These two ...
Source: Mass Device - July 3, 2017 Category: Medical Devices Authors: Fink Densford Tags: 510(k) Food & Drug Administration (FDA) Oncology Regulatory/Compliance Varian Medical Systems Source Type: news

City approves bond funding for high-tech cancer center
After over a year of uncertainty, the Emory Proton Therapy Center finally is slated for completion. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - June 30, 2017 Category: American Health Authors: Ellie Hensley Source Type: news

FDA clears Varian's Halcyon rad therapy system
The U.S. Food and Drug Administration (FDA) has cleared radiation oncology...Read more on AuntMinnie.comRelated Reading: Varian to build radiation oncology centers in Vietnam Varian awarded Thai proton therapy contract Varian installs proton therapy system in Fla. Varian launches Halcyon radiation therapy unit at ESTRO Varian adds to revenues in Q2 (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 29, 2017 Category: Radiology Source Type: news

IBA to show updated synthesizer at SNMMI 2017
Proton therapy developer Ion Beam Applications (IBA) plans to show an upgraded...Read more on AuntMinnie.comRelated Reading: IBA posts healthy Q1 revenue rise IBA posts healthy revenue for fiscal 2016 IBA, partners to bring proton therapy to Ala. IBA, Nelco ink North American deal Japan OKs IBA's proton therapy system (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 8, 2017 Category: Radiology Source Type: news

Varian to build radiation oncology centers in Vietnam
Radiation oncology firm Varian Medical Systems has signed an agreement with...Read more on AuntMinnie.comRelated Reading: Varian awarded Thai proton therapy contract Varian installs proton therapy system in Fla. Varian launches Halcyon radiation therapy unit at ESTRO Varian adds to revenues in Q2 Varian launches direct sales in South Africa (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 5, 2017 Category: Radiology Source Type: news

Varian Selected to Provide First Proton Therapy System in Thailand
PALO ALTO, Calif., May 24, 2017 -- (Healthcare Sales & Marketing Network) -- Varian Medical Systems (NYSE: VAR), today announced it has been selected through its distributor, Business Alignment, to supply and install a Varian ProBeam® Compact single-r... Devices, Oncology Varian Medical Systems, ProBeam, proton therapy, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 24, 2017 Category: Pharmaceuticals Source Type: news

World-first proton CT images create a new vision for cancer treatment
(University of Lincoln) An international team of scientists has produced the world's first computerized tomography (CT) images of biological tissue using protons -- a momentous step towards improving the quality and feasibility of Proton Therapy for cancer sufferers around the world. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 11, 2017 Category: International Medicine & Public Health Source Type: news

Japan approves Varian Medical ’ s ProBeam proton therapy
Varian Medical (NYSE:VAR) said today it won Shonin approval from the Japanese Ministry of Health, Labor and Welfare for its ProBeam system designed for proton therapy. Proton therapy is designed for precise treatment of certain types of cancer while providing potentially fewer side effects than conventional radiation therapy, the Palo Alto, Calif.-based company said. Varian claims that its ProBeam system is the 1st to offer fully-integrated intensity modulated proton therapy. “We are very pleased that the ProBeam system has now received Shonin approval. This approval is an important step in the growing avai...
Source: Mass Device - May 10, 2017 Category: Medical Devices Authors: Fink Densford Tags: Oncology Regulatory/Compliance Varian Medical Systems Source Type: news

Toshiba, Japanese QST tout heavy-ion therapy breakthrough
Toshiba (TYO:6502) said today that it, along with Japan’s National Institutes for Quantum and Radiological Science and Technology have developed a novel pencil beaming scanning system which they claim significantly reduces the size of the system without lowered performance. The company said that the newly designed system can be mounted on a rotating gantry with superconducing beam bending magnets, which will lead to further downsizing and weight reductions. Toshiba said it will release more details of the device this week at the 56th Annual COnference of the Particle Therapy Co-operation group in Yokohama. ...
Source: Mass Device - May 10, 2017 Category: Medical Devices Authors: Fink Densford Tags: Oncology Research & Development Toshiba Source Type: news

IBA posts healthy Q1 revenue rise
Double-digit revenue increases in all its business segments propelled proton...Read more on AuntMinnie.comRelated Reading: IBA posts healthy revenue for fiscal 2016 IBA, partners to bring proton therapy to Ala. IBA, Nelco ink North American deal Japan OKs IBA's proton therapy system IBA reaches treatment milestone, wins UAE order (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 10, 2017 Category: Radiology Source Type: news

Varian ProBeam Proton Therapy System Receives Shonin Approval
Advanced proton therapy systems from Varian now available to cancer centers in Japan PALO ALTO, Calif., May 10, 2017 -- (Healthcare Sales & Marketing Network) -- Varian Medical Systems (NYSE: VAR) today announced it has received Shonin approval from th... Devices, Oncology, Regulatory Varian Medical Systems, ProBeam, proton therapy, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 10, 2017 Category: Pharmaceuticals Source Type: news

7 medtech stories we missed this week: May 5, 2017
[Image from unsplash.com]From Biomerics’s $38.5 million expansion in Salt Lake City to new study results and partnerships, here are 7 medtech stories we missed this week but thought were still worth mentioning. 1. Biomerics opening new corporate HQ Biomerics announced in a May 1 press release that it is moving its corporate headquarters in Salt Lake City. The new facility will be 230,000 sq. ft and will be located in the International Center. It will have corporate offices, engineering offices, research and development labs and cleanroom manufacturing. Biomerics is expected to invest $38.5 million in the expansi...
Source: Mass Device - May 5, 2017 Category: Medical Equipment Authors: Danielle Kirsh Tags: Clinical Trials Food & Drug Administration (FDA) Imaging Pre-Market Approval (PMA) Regulatory/Compliance Research & Development Accuray Inc. Biomerics Glytec medPhoton MedTech Mevion Medical Systems Neural Analytics RAPS Refocu Source Type: news

PET/CT helps assess pediatric brain tumor therapy
In a new study published in the May issue of the Journal of Nuclear Medicine,...Read more on AuntMinnie.comRelated Reading: SNMMI: FDOPA-PET/MRI monitors pediatric brain tumors SNMMI: PET, MRI may predict pediatric brain tumor outcomes SNMMI: FET-PET aids pediatric brain cancer patients SNM: PET/MRI helps tumor staging for pediatric patients Proton therapy offers hope to pediatric brain cancer patients (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 3, 2017 Category: Radiology Source Type: news

IMRT vs Proton Therapy in Esophageal Cancer
This video reviews the advantages and disadvantages of IMRT and proton therapy for the treatment of esophageal cancer. (Source: CancerNetwork)
Source: CancerNetwork - May 3, 2017 Category: Cancer & Oncology Authors: Steven H. Lin, MD, PhD Tags: Videos Gastrointestinal Cancers Source Type: news

Mevion joins forces with MedPhoton
Proton therapy developer Mevion Medical Systems has inked a strategic agreement...Read more on AuntMinnie.comRelated Reading: Mevion completes milestone installation Mevion completes Fla. installation Mevion, RaySearch partner on info system Mevion to sharpen pencil-beam scanning at ASTRO ProNova joins forces with MedPhoton (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 2, 2017 Category: Radiology Source Type: news

Proton therapy dev ProTom Int ’ l raises $30m
Proton therapy tech developer ProTom International said today it raised $30 million in a new round of funding. The funding round will provide $30 million to the company by the end of June 2017, with $10 million already funded as of March, the company said in a press release. ProTom produces the Radiance 330 proton therapy system, designed to offer focused proton therapy treatments to cancer patients. The company said that Massachusetts General Hospital is slated to install a Radiance 330 system, which it expects will be operational in late 2017. “ProTom’s Radiance 33 is a disruptive technology that signifi...
Source: Mass Device - April 7, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Oncology ProTom International Source Type: news

IBA Molecular forms Curium as new radiopharmacy player
Radiopharmacy vendor IBA Molecular has combined with recent acquisition Mallinckrodt...Read more on AuntMinnie.comRelated Reading: IBA posts healthy revenue for fiscal 2016 IBA, partners to bring proton therapy to Ala. IBA Molecular finalizes purchase of Mallinckrodt unit IBA, Nelco ink North American deal IBA cyclotron opens ahead of schedule (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 6, 2017 Category: Radiology Source Type: news

Varian Medical Systems Names New CFO
PALO ALTO, Calif., April 5, 2017 -- (Healthcare Sales & Marketing Network) -- Varian Medical Systems (VAR) today announced it has named Gary E. Bischoping, Jr. of Dell Technologies as Chief Financial Officer effective May 8, 2017. Bischoping, 49, will re... Devices, Oncology, Personnel Varian Medical Systems, ProBeam, proton therapy, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 5, 2017 Category: Pharmaceuticals Source Type: news

From the room next door to the next planet over
The new Albert Chadwick Research Room inside the Roberts Proton Therapy Center is no ordinary laboratory space. In fact, there ’s nothing else quite like it anywhere else in the United States, and whether it’s treating patients with cancer or helping NASA with its plans to send astronauts to Mars, the discoveries that could propel scientists forward will happen right here. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - March 27, 2017 Category: Science Source Type: news

Cancer therapy: Tracking real-time proton induced radiation chemistry in water
Proton therapy is a promising form of radiation treatment used to kill cancerous cells and effectively halt their rapid reproduction, and the fundamental understanding for it is contained in the radiation induced water chemistry that occurs immediately after the interaction. The ensuing processes are therefore a subject of considerable scientific interest. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - March 27, 2017 Category: Science Source Type: news

Tracking real-time proton induced radiation chemistry in water
(American Institute of Physics) Proton therapy is a promising form of radiation treatment used to kill cancerous cells and effectively halt their rapid reproduction, and the fundamental understanding for it is contained in the radiation induced water chemistry that occurs immediately after the interaction. The ensuing processes are therefore a subject of considerable scientific interest. Researchers describe their work exploring this ionization with an experimental setup, with enhanced temporal resolution, in this week's Applied Physics Letters. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 27, 2017 Category: Global & Universal Source Type: news

IBA posts healthy revenue for fiscal 2016
Proton therapy developer Ion Beam Applications (IBA) has posted healthy revenue...Read more on AuntMinnie.comRelated Reading: IBA, partners to bring proton therapy to Ala. IBA, Nelco ink North American deal Japan OKs IBA's proton therapy system IBA reaches treatment milestone, wins UAE order IBA wins proton therapy contract in China (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 23, 2017 Category: Radiology Source Type: news

Proton Therapy Improves Outcomes in Recurrent Lung Cancer Proton Therapy Improves Outcomes in Recurrent Lung Cancer
Reirradiation with intensity-modulated proton therapy appears safe and improved outcomes in patients with recurrent lung cancer.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 22, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Proton Therapy Reirradiation Safe, Effective for Recurrent Thoracic Tumors
The use of reirradiation with intensity-modulated proton therapy yielded strong overall survival with limited toxicity in patients with thoracic tumors, potentially offering a new option in this patient population. (Source: CancerNetwork)
Source: CancerNetwork - March 20, 2017 Category: Cancer & Oncology Authors: Dave Levitan Tags: Lung Cancer News Source Type: news

Advanced form of proton therapy shows promise for treating lung cancer recurrence
An advanced form of image-guided radiation therapy, known as intensity modulated proton therapy (IMPT), has shown early promise for the treatment of recurrent lung cancer, according to new research. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - March 17, 2017 Category: Science Source Type: news

Advanced form of proton therapy shows promise for treating lung cancer recurrence
(University of Texas M. D. Anderson Cancer Center) An advanced form of image-guided radiation therapy, known as intensity modulated proton therapy (IMPT), has shown early promise for the treatment of recurrent lung cancer, according to new research from The University of Texas MD Anderson Cancer Center. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 17, 2017 Category: Cancer & Oncology Source Type: news

Proton therapy offers new treatment possibility for recurrent lung cancer
(American Society for Radiation Oncology) A new study offers hope for patients with recurrent lung cancer, who historically have been considered ineligible for curative treatment. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 16, 2017 Category: Cancer & Oncology Source Type: news

Personalized medicine, proton therapy, more advances in lung cancer at upcoming symposium
(American Society for Radiation Oncology) The press program for next week's 2017 Multidisciplinary Thoracic Cancers Symposium features research advances in lung cancer including immunotherapy, proton therapy and liquid biopsy, among others. Researchers will share their findings in a series of news briefings that will be held on-site and simultaneously webcast from the San Francisco Marriott Marquis. Embargoed study releases will be provided to registered reporters before the briefings, and outside experts in lung cancer are available on request. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 9, 2017 Category: Cancer & Oncology Source Type: news

Proton center at St. Vincent ’s gets OK
Birmingham's Providence Proton is partnering with St. Vincent's - Birmingham to bring a new advanced proton therapy cancer treatment to the Magic City. As we previously reported, UAB is also enjoying a $50 million proton therapy partnership and plans to bring a new proton treatment building into its health care arsenal. "In life, everyone will at some point be touched by cancer either personally or through family or friends. Providence Proton is honored to be part of this team of partners," said… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - March 7, 2017 Category: Biotechnology Authors: Tim Steere Source Type: news

IBA, partners to bring proton therapy to Ala.
Proton therapy developer Ion Beam Applications (IBA) is partnering with several...Read more on AuntMinnie.comRelated Reading: IBA, Nelco ink North American deal Japan OKs IBA's proton therapy system IBA reaches treatment milestone, wins UAE order IBA wins proton therapy contract in China IBA cyclotron opens ahead of schedule (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 6, 2017 Category: Radiology Source Type: news

UAB to bring proton therapy for advanced cancer treatment to Birmingham
(University of Alabama at Birmingham) The University of Alabama at Birmingham will partner with Proton International to bring proton therapy, one of the most technically advanced forms of cancer-killing radiation, to Alabama. Proton therapy delivers a more precise dose of radiation to a tumor and can avoid damage to healthy surrounding tissue better than conventional X-ray radiation. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 16, 2017 Category: Cancer & Oncology Source Type: news

ZDi Solutions, LLC Announces Justin Sims as Executive Vice President of Sales
KNOXVILLE, Tenn., Jan. 30, 2017 -- (Healthcare Sales & Marketing Network) -- ZDi Solutions, LLC announced today that Justin Sims has joined the team as the new Executive Vice President of Sales. Justin brings over 25 years of domestic and international sa... Devices, Oncology, Personnel ZDi Solutions, Z-System, patient positioning, radiotherapy, proton therapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 30, 2017 Category: Pharmaceuticals Source Type: news